Raymond James Financial
BNGO icon

Raymond James Financial’s Bionano Genomics BNGO Stock Holding History

Raymond James Financial’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-74
Closed -$243 – 5191
2025
Q2 		$243 Buy
+74
New +$276 ﹤0.01% 6759
2025
Q1 		– Sell
-329
Closed -$5.7K – 4829
2024
Q4 		$5.7K Buy
+329
New +$5.62K ﹤0.01% 4784

Other funds holding BNGO

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAM
Carret Asset Management New York $1.02B AUM 26.95% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Raymond James Financial's BNGO Position: Q3 2025 in Review

Raymond James Financial sold out of Bionano Genomics (BNGO) in Q3 2025, closing a stake of 74 shares — an estimated $243 sold.

Raymond James Financial first reported a position in BNGO in Q4 2024 and held it in 2 quarters. The position peaked at $5.7K in Q4 2024. 32 funds tracked by Wall St. Rank hold BNGO as of Q3 2025.

  • Raymond James Financial reported no remaining Bionano Genomics position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 74 Bionano Genomics shares in Q3 2025, an estimated $243.
  • Raymond James Financial first reported a position in Bionano Genomics in Q4 2024 and held it in 2 quarters.
  • Raymond James Financial's Bionano Genomics position peaked at $5.7K in Q4 2024.
  • 32 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.